Introduction
Age-related macular degeneration (AMD) is the predominant cause of blindness in high income countries 1 . It is of growing importance in other settings, in association with increasing longevity. 2 AMD is considered to be a complex multi-factorial disorder, involving an interplay between genetic, environmental and lifestyle factors, such as smoking, 3 obesity, 4 cardiovascular disease, 5 macular pigment, 6 sunlight exposure, 7 diet, 8 high BMI 9 and physical activity 10 .
It has been known for some time that dietary factors can modulate AMD risk 11 12 .
Epidemiological studies have demonstrated that diets high in antioxidant nutrients (vitamins C and E, carotenoids such as lutein and zeaxanthin and fruit and vegetables rich in these nutrients) or zinc are associated with a decreased occurrence of AMD. Studies have also shown that a high dietary intake of trans fats is a risk factor for late AMD, 13 while a higher intake of fish or ω -3 fatty acids is protective against AMD 13 .
However the evidence from clinical trials is less consistent. While high dose multivitamin supplementation slowed the progression of AMD, 14 a trial which added lutein and zeaxanthin supplements with or without omega-3 fatty acids to the AREDS supplements showed no substantial added beneficial effect of the AREDS supplements on AMD progression (AREDS2). 15 However, in the pre-specified analyses of those persons with the lowest dietary intake of lutein, there was a beneficial effect of lutein for retarding the progression to late AMD, especially the neovascular form. 16 . Most studies to date have focused on individual food groups or nutrients, yet it is known that diet is a multifactorial lifestyle behaviour, with particular foods frequently consumed together, depending on the cultural, geographical and economic context of the individual. Therefore researchers are increasingly attempting to analyse relationships between dietary patterns or overall diet and disease, rather than specific foods or nutrients 17 18 20 . To date these analyses have been undertaken in populations living in defined geographical locations such as Melbourne, Australia, 17 US CAREDS participants 19 or in US AREDS participants 18 20 consequently, there is a greater likelihood that the dietary patterns of the individuals in these studies was similar. This was particularly evident in the application of a Mediterranean diet score to CAREDS participants 19 in that high scores were uncommon in this sample (0.04%). As dietary patterns vary by culture, and availability of local food is subject to strong regional influences, a lack of heterogeneity of populations in the prior studies may have reduced the power to detect associations with AMD outcomes. By contrast the European Eye (EUREYE) Study enrolled participants from 7 countries across Europe with widely differing cultures and dietary patterns, thus providing an interesting context in which to investigate links between diet and AMD. Notably the dietary questionnaire was modified to reflect locally available foods. For these reasons we aimed to examine the association between adherence to a Mediterranean diet and prevalence of AMD in countries ranging from Southern to Northern Europe.
Methods

Study Population
We The study design and methodology has been published elsewhere 7 21-26 .
Participants attended the examination center, where they were first interviewed by trained fieldworkers, underwent an ophthalmological examination and gave a blood sample. Information collected by the interviewers included quantified smoking and alcohol use and a brief medical history, detailed questionnaire on outdoor exposure throughout working life and in retirement, and a dietary assessment (described in detail below).
Dietary Assessment Methodology
During the interview, dietary intake during the previous 12 months was assessed by using a semi-quantitative food-frequency questionnaire (FFQ). We used the UK 30 . For each study participant, the nutrient intake was calculated by multiplying the intake frequency for each food item by the nutrient content for the portion size. Dietary intakes were adjusted by energy using the residual method.
Assessing adherence to Mediterranean Diet Score (MDS)
We used a previously published MDS to classify participants according to their responses on the FFQ. 32 The composite score (range 0-9) captures consumption of key food items, such as olive oil (1 point for > 1 spoon/day), wine (1 point for > 1 glass/day), fruit (1 point for > 1 serving/day), vegetables or salad (1 point for > 1 serving/day), fish (1 point for > 3 servings/week), legumes (1 point for > 2 servings/week) and low consumption of meat or meat products (1 point for < 1 serving/day). A further point was awarded for a daily serving or more of both fruits and vegetables, and a final point was awarded when either consumption of both white bread (<1 serving/day) and rice (< 1 serving/week) was low or when consumption of whole-grain bread was high (>5 servings/week).
Assessment of age-related macular degeneration.
After pupillary dilation with tropicamide 0.5% and phenylephrine 5%, two 35° nonsimultaneous stereoscopic digitized color fundus images were obtained of each eye, centered on the fovea.
The fundus images were sent to a single reading centre (Erasmus University Rotterdam) and graded using the International Classification System for Age-Related ). This grading system had been validated within the Rotterdam Eye Study. 34 Large drusen (≥125 µm) in any grade of early AMD were additionally categorised as a separate outcome.
Blood Samples
A non-fasting blood sample was collected. Participants were advised to consume a standard breakfast before attending the clinic, e.g. not eating fruit and fruit juice prior to coming into the centre. Samples were anti-coagulated with EDTA or were allowed to clot. Samples were kept at room temperature for at least one hour (serum) or kept at 4°C and centrifuged as soon as possible (plasma), but all samples were centrifuged a maximum of 2 hours after collection. Serum or plasma was aliquoted as required for biochemical analysis. A plasma sample was precipitated by adding 100 µl of plasma to 900 µl of 5% metaphosphoric acid for vitamin C analysis, and all samples were stored at either -20°C or less than -70°C in the short term (depending on what was locally available) and shipped at regular intervals to the Belfast centre (the biochemical analysis centre) where they were stored at -80°C. DNA was extracted from the stored blood sample and genotyped for Y204H (rs1061170).
Plasma ascorbic acid concentrations were determined according to Vuillemier and Keck 35 . Serum concentrations of retinol, α-tocopherol, lutein, zeaxanthin, βcryptoxanthin, α-carotene, β-carotene and lycopene were measured by reverse phase high performance liquid chromatography (HPLC) 36 . Assays were standardised against appropriate National Institute of Standards and Technology reference materials.
Statistical analysis
Statistical analysis was carried out using Stata version 13 (Stata Corp, College Station, Texas). We categorised the MDS score into 4 groups (MDS of <=4; 5; 6; >6) as this provided a more even spread across groups. We used univariable regression in people without signs of AMD to investigate potential confounders expected to be associated with MDS and AMD, either negatively or positively: demographic (age, sex and education) lifestyle (smoking, alcohol, body mass index, and supplement use), comorbidity (diabetes, cardiovascular disease). We also investigated the relationship between MDS and dietary and serum biomarkers of nutritional status related to food groups which predominate within the MDS. Blood analyses were seasonally adjusted and dietary nutrients were energy adjusted. We undertook multivariable logistic regression to investigate the association of MDS score with AMD and with large drusen. We investigated whether rs1061170 modified any association with AMD and diet score as has been previously reported. 20 All analyses took account of the study design of the seven study centers by use of survey estimators or robust errors.
Results
Of 5040 EUREYE participants, full dietary data was available in 4753 participants (109 nvAMD, 49 with GA, 2333 early AMD, 641 with large drusen and 2262 without signs of AMD. The mean age of participants was 73.2 (SD, 5.6) and 55% were women.
MDS and participant characteristics
In univariable analysis in people with no signs of AMD, significant trends were observed for MDS score with sex, education, and alcohol intake, but no association with age ( p<0.0001. Figure 1 illustrates the proportion of participants in each country reporting a particular item of the MDS score. Age-standardised mean (95% CI) MDS scores by AMD grade showed a weak trend from no AMD to late AMD. AMD 0 5.03 (4.6- The MDS diet score correlated well with serum levels of vitamin C, lutein, zeaxanthin and beta-cryptoxanthin, all biomarkers of fruit and vegetable intake. MDS was also negatively associated with saturated fatty acid and n-6 PUFA intake and positively associated with n-3 PUFA intake and dietary lutein plus zeaxanthin.
MDS and serum levels of antioxidants
MDS and late AMD (nvAMD and GA)
Increasing MDS was significantly associated with reduced odds of nvAMD (Table 2 ), in both the unadjusted analysis and also when adjusted for potential confounders such as age, sex, country, education, smoking, drinking, self-reported history of CVD, aspirin consumption and diabetes. A score of >6 was associated with an approximately 50% reduction in the adjusted odds ratio of developing nvAMD compared to those with a score of 4 or less.
Preliminary analyses showed no association with GA and we did not run further analyses on GA with full data on diet score and confounders.
MDS and early AMD (grade 1-3)
For all early AMD participants (grades 1-3), there was no significant relationship with MDS (Table 3 ). There was a weak trend (p=0.1) between MDS and large drusen, those in the highest category of MDS had a significant 20% reduced odds compared to those in the lowest, p=0.05. Addition of plasma or dietary lutein and zeaxanthin did not affect the results for early AMD or large drusen.
We also examined whether the results for the diet score varied according to Y204H (rs1061170) genotype. We found no significant interactions between rs1061170 and the full diet score in the association with nvAMD (p=0.89), early AMD (p=0.28) or large drusen, p=0.99. We further explored whether the association with diet score was explained by the key macular carotenoids lutein and zeaxanthin. Addition of either dietary or plasma lutein and zeaxanthin made no material difference to the results for the diet score for any outcome.
Discussion
The current analysis has exploited the large regional differences in food consumption found in the EUREYE study to examine the relationship between diet and AMD in Europe. We have shown that increased adherence to a Mediterranean diet was associated with significantly reduced odds of having nvAMD. MDS has previously been inversely associated with cardiovascular disease, cancer and mortality [37] [38] [39] and more recently progression to advanced AMD 20 . Our current findings provide further evidence for the potential value of adhering to this diet on eye health.
We did not find a significant association between early AMD and MDS. However the classification of early AMD was based on color image grading which may not detect some features of early AMD. Many of the individual constituents of the MDS have previously been identified as associated with reduced prevalence of incidence of AMD, such as higher fruit and vegetable 40 , reduced red meat 41 , lower glycaemic index 42 and higher fish intake 23 . It is also interesting that carotenoids such as lutein and zeaxanthin, which have well-established associations with AMD, but are also established biomarkers of fruit and vegetable intake, were significantly associated with MDS in those without signs of AMD. However the association we observed between MDS and neovascular AMD was not explained by lutein and zeaxanthin. This is not surprising because the MDS score is based on hypothesised benefits of food patterns rather than single nutrients and therefore includes other important nutrients relevant to late AMD.
Dietary patterns rather than individual components are increasingly being studied in relation to AMD. Various methodological approaches have been taken but tend to fall into two broad categories. The first are a posteriori approaches, including the use of factor and principal component analysis to identify patterns which are then related to the disease under investigation. 17 18 This is a data driven approach, and requires no a priori hypothesis of what factors or food groups within the overall diet may be important. The second method uses a priori scores to assess an individual's adherence to a specific diet such as the Mediterranean diet 20 or a set of dietary recommendations 41 43 , and therefore requires an a priori hypothesis of what may be significant. In this analysis, we have used the latter approach.
Several studies have evaluated dietary patterns and AMD. In the Melbourne Collaborative Cohort Study principal components analysis revealed 6 distinct dietary factors, the factor characterized by high fruit and nut intake demonstrated a similar risk reduction for advanced AMD to the current study (0R 0.45; 95% confidence interval, 0.28-0.87). 17 Conversely a diet characterised by high cakes, sweet biscuits and desserts was associated with a higher prevalence of advanced AMD. No significant associations were reported between early AMD and dietary factors.
Evaluation of dietary data from the baseline Age-related eye disease study (AREDS) identified two major components which the investigators named Oriental and Western patterns 24 . The oriental pattern was associated with significantly reduced odds of both early and advanced AMD while the western patterns was associated with significantly increased odds of both early and advanced AMD. While the associations were noted for both early and advanced AMD, the strength of the associations were much greater for advanced AMD. A score based approach has been applied within the Carotenoids in Age-related Eye Disease Study (CAREDS).
Responses to a food frequency questionnaire were converted to a modified 2005
Healthy Eating Index and those in the highest quintile compared to the lowest quintile of the index had 46% lower odds of developing early AMD 19 . Most recently, in an analysis of the association of adherence to the Mediterranean diet and genetic susceptibility with progression to advanced AMD, higher adherence to the Mediterranean Diet was associated with reduced risk of progression to advanced AMD; the association was only seen in subjects carrying the carrying none or one CFH Y402H risk alleles and not observed in those at the highest risk with two alleles 20 . In our analysis we did not find that the association of diet score with AMD was modified by Y204H alleles. The small number of cases with nvAMD meant we lacked power to investigate significant gene/diet interactions (as found in that paper), but had adequate numbers for analyses in early AMD.
One of the strengths of our study in a European older population was that it was carried out prior to the widespread usage of supplements for AMD and also prior to public awareness of the relationship between dietary factors and AMD, thereby reducing the potential of recall bias by those with a diagnosis of AMD. In addition the grading of the fundus photographs was undertaken by independent graders with no knowledge of any characteristics of the participants including the nutrition data.
Comparison of the MDS score with serum antioxidants also provides us with a helpful insight into what constituents of the diet that the MDS is reflecting (Table 1) . It also provides a degree of construct validity to the MDS score. This is a cross-sectional study therefore no causal inferences can be made regarding the associations noted. This study was also carried out prior to the routine The MDS score ranges from 0-9. The 9 points can be awarded according to consumption of the following dietary items: 
